Compare Abbott Laboratories (ABT) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Abbott Laboratories trades at $95.13 (market cap $166.94B), while iShares 1 3 Year Treasury Bond ETF trades at $81.85. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares 1 3 Year Treasury Bond ETF pays none, and Abbott Laboratories is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ABT | SHY | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | Fixed Income |
52-Week High | $136.62 | $83.18 |
52-Week Low | $82.57 | $81.84 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
SHY trades at $81.98 with minimal daily movement (+0.05%). Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators remain neutral. The ETF maintains consistent dividend distributions of $0.24 per share quarterly. Recent bond market focus highlights investor interest in Treasury income products amid rising yield expectations and Federal Reserve policy uncertainty.
The outlook remains cautious given bearish technical signals and bond market volatility. Investment opportunity exists for income-focused investors seeking Treasury exposure, though risks include interest rate sensitivity and Fed policy shifts. Current market conditions favor defensive positioning with attention to yield curve movements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
